跳转至内容
Merck
CN
  • Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss.

Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle loss.

NPJ Regenerative medicine (2022-10-21)
Andrew Clark, Subhadip Ghatak, Poornachander Reddy Guda, Mohamed S El Masry, Yi Xuan, Amy Y Sato, Teresita Bellido, Chandan K Sen
摘要

This work rests on our non-viral tissue nanotransfection (TNT) platform to deliver MyoD (TNTMyoD) to injured tissue in vivo. TNTMyoD was performed on skin and successfully induced expression of myogenic factors. TNTMyoD was then used as a therapy 7 days following volumetric muscle loss (VML) of rat tibialis anterior and rescued muscle function. TNTMyoD is promising as VML intervention.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
凝血酶 来源于牛血浆, ≥60 NIH units/mg protein (biuret)